Article Details

China approves CanSino, CSPC mRNA vaccines for clinical trial - CGTN

Retrieved on: 2022-04-04 19:04:13

Tags for this article:

Click the tags to see associated articles and topics

China approves CanSino, CSPC mRNA vaccines for clinical trial - CGTN. View article details on hiswai:

Excerpt

China's medical products regulator has approved two messenger RNA (mRNA) COVID-19 vaccines for clinical trial, expecting to replenish country's ...

Article found on: news.cgtn.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up